HomeNASDAQ:MYL

NASDAQ:MYL

Teva Pharmaceutical Gaining Momentum After FDA Approves EpiPen

Teva Pharmaceutical Gaining Momentum After FDA Approves EpiPen

August 17, 2018

Mylan NV Just Wrapped Up the $465 Million EpiPen Settlement

Mylan NV Just Wrapped Up the $465 Million EpiPen Settlement

August 17, 2017

Mylan N.V. Lowers 2017 Forecast Due to Delays in New Drugs

Mylan N.V. Lowers 2017 Forecast Due to Delays in New Drugs

August 9, 2017

Mylan Faces More Criticism for Excessive Pay Package to Its Top Executives

Mylan Faces More Criticism for Excessive Pay Package to Its Top Executives

June 23, 2017

Adamis Pharmaceuticals’ Shares Hits New Highs After Allergic-Reaction Treatment Drug Gains FDA Approval

Adamis Pharmaceuticals’ Shares Hits New Highs After Allergic-Reaction Treatment Drug Gains FDA Approval

June 15, 2017